| Application no. and date | 12005456.4 (espacenet) (Federated) (European Patent Register), 20040514 | | Patent/reg. no. and date | DK/EP 2537524, 20160706 | | Publication date | 20121226 | | Priority no. and date | US 471017 P, 20030515, US 489270 P, 20030721, US 514930 P, 20031027, US 517338 P, 20031104 | | EP pub. no. and date |
EP 2537524 20121226 | | Effective date | | | Applicant/owner | Ampio Pharmaceuticals, Inc., 373 Inverness Parkway, Suite 200
Englewood, CO 80112, US | | Applicant ref. no. | YOUNG P108580EPD | | Inventor | Bar-Or, David, 900 E. Oxford Lane
Englewood Colorado 80110, US, Bar-Or, Raphael, 1720 Wynkoop Street 214
Denver CO 80202, US, SHIMONKEVITZ, Richard, 8475 Crow Ct.
Larkspur, CO 80118, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/495 (2006.01) , A61K 38/12 (2006.01) , A61K 45/06 (2006.01) , A61P 37/06 (2006.01) , C07D 241/08 (2006.01) | | Title | Behandling af T-cellemedierede sygdomme | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|